Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia
2
조회
0
다운로드
32
인용
0
참고문헌
키워드
초록
Aging processes are inevitably accompanied by structural and functional changes in vital organs. Skeletal muscle, which accounts for 40% of total body weight, deteriorates quantitatively and qualitatively with aging. Skeletal muscle is known to play diverse crucial physical and metabolic roles in humans. Sarcopenia is a condition characterized by significant loss of muscle mass and strength. It is related to subsequent frailty and instability in the elderly population. Because muscle tissue is involved in multiple functions, sarcopenia is closely related to various adverse health outcomes. Along with increasing recognition of the clinical importance of sarcopenia, several international study groups have recently released their consensus on the definition and diagnosis of sarcopenia. In practical terms, various skeletal muscle mass indices have been suggested for assessing sarcopenia: appendicular skeletal muscle mass adjusted for height squared, weight, or body mass index. A different prevalence and different clinical implications of sarcopenia are highlighted by each definition. The discordances among these indices have emerged as an issue in defining sarcopenia, and a unifying definition for sarcopenia has not yet been attained. This review aims to compare these three operational definitions and to introduce an optimal skeletal muscle mass index that reflects the clinical implications of sarcopenia from a metabolic perspective
Abstract
Aging processes are inevitably accompanied by structural and functional changes in vital organs. Skeletal muscle, which accounts for 40% of total body weight, deteriorates quantitatively and qualitatively with aging. Skeletal muscle is known to play diverse crucial physical and metabolic roles in humans. Sarcopenia is a condition characterized by significant loss of muscle mass and strength. It is related to subsequent frailty and instability in the elderly population. Because muscle tissue is involved in multiple functions, sarcopenia is closely related to various adverse health outcomes. Along with increasing recognition of the clinical importance of sarcopenia, several international study groups have recently released their consensus on the definition and diagnosis of sarcopenia. In practical terms, various skeletal muscle mass indices have been suggested for assessing sarcopenia: appendicular skeletal muscle mass adjusted for height squared, weight, or body mass index. A different prevalence and different clinical implications of sarcopenia are highlighted by each definition. The discordances among these indices have emerged as an issue in defining sarcopenia, and a unifying definition for sarcopenia has not yet been attained. This review aims to compare these three operational definitions and to introduce an optimal skeletal muscle mass index that reflects the clinical implications of sarcopenia from a metabolic perspective
참고문헌 (40)
- Frontera WR, "Skeletal muscle: a brief review of structure and function", Calcif Tissue Int, 96, pp.183~195 (2015)
- 이승원, "Appendicular Skeletal Muscle Mass and Insulin Resistance in an Elderly Korean Population: The Korean Social Life, Health and Aging Project-Health Examination Cohort", Diabetes and Metabolism Journal, 39(1), pp.37~45 (2015), 대한당뇨병학회
- Hughes VA, "Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health", J Gerontol A Biol Sci Med Sci, 56, pp.B209~B217 (2001)
- Cheng Q, "A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women: reference values, prevalence, and association with bone mass", J Bone Miner Metab, 32, pp.78~88 (2014)
- Fielding RA, "Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia", J Am Med Dir Assoc, 12, pp.249~256 (2011)
- 최경묵, "Sarcopenia and Sarcopenic Obesity", Endocrinology and Metabolism, 28(2), pp.86~89 (2013), 대한내분비학회
- Hun-Tae Kim, "An analysis of age-related loss of skeletal muscle mass and its significance on osteoarthritis in a Korean population", The Korean Journal of Internal Medicine, 31(3), pp.585~593 (2016), 대한내과학회
- Ochi M, "Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men", Atherosclerosis, 212, pp.327~332 (2010)
- He H, "Relationship of sarcopenia and body composition with osteoporosis", Osteoporos Int, 27, pp.473~482 (2016)
- Rexford S. Ahima, "Connecting Myokines and Metabolism", Endocrinology and Metabolism, 30(3), pp.235~245 (2015), 대한내분비학회
- Chin SO, "Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009", PLoS One, 8, pp.e60119~ (2013)
- Atkins JL, "Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men", J Am Geriatr Soc, 62, pp.253~260 (2014)
- 문준성, "The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease", Diabetes and Metabolism Journal, 37(4), pp.278~285 (2013), 대한당뇨병학회[DOI]
- Cruz-Jentoft AJ, "Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39, pp.412~423 (2010)
- Dam TT, "An evidence-based comparison of operational criteria for the presence of sarcopenia", J Gerontol A Biol Sci Med Sci, 69, pp.584~590 (2014)
- Kim JH, "Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men", J Gerontol A Biol Sci Med Sci, 69, pp.1244~1252 (2014)
- Cawthon PM, "Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness", J Gerontol A Biol Sci Med Sci, 69, pp.567~575 (2014)
- Baumgartner RN, "Epidemiology of sarcopenia among the elderly in New Mexico", Am J Epidemiol, 147, pp.755~763 (1998)
- Janssen I, "Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability", J Am Geriatr Soc, 50, pp.889~896 (2002)
- Chen LK, "Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia", J Am Med Dir Assoc, 15, pp.95~101 (2014)
- Kim KM, "Cardiometabolic implication of sarcopenia: The Korea National Health and Nutrition Examination Study (KNHANES) 2008-2010", IJC Metab Endocr, 4, pp.63~69 (2014)
- Bischoff-Ferrari HA, "Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older", Osteoporos Int, 26, pp.2793~2802 (2015)
- Yoshida D, "Development of an equation for estimating appendicular skeletal muscle mass in Japanese older adults using bioelectrical impedance analysis", Geriatr Gerontol Int, 14, pp.851~857 (2014)
- Kim JH, "Assessment of appendicular skeletal muscle mass by bioimpedance in older community-dwelling Korean adults", Arch Gerontol Geriatr, 58, pp.303~307 (2014)
- Gallagher D, "Appendicular skeletal muscle mass: effects of age, gender, and ethnicity", J Appl Physiol, 83, pp.229~239 (1997)
- Sanada K, "A cross-sectional study of sarcopenia in Japanese men and women:reference values and association with cardiovascular risk factors", Eur J Appl Physiol, 110, pp.57~65 (2010)
- Frisoli A Jr, "Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women’s Health and Aging Study (WHAS) II", Bone, 48, pp.952~957 (2011)
- Looker AC, "Dysmobility syndrome and mortality risk in US men and women age 50 years and older", Osteoporos Int, 26, pp.93~102 (2015)
- Newman AB, "Sarcopenia: alternative definitions and associations with lower extremity function", J Am Geriatr Soc, 51, pp.1602~1609 (2003)
- Lim S, "Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLo-SHA)", Diabetes Care, 33, pp.1652~1654 (2010)
- Kim MK, "Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009", J Clin Endocrinol Metab, 96, pp.3250~3256 (2011)
- Woo J, "Defining sarcopenia in terms of incident adverse outcomes", J Am Med Dir Assoc, 16, pp.247~252 (2015)
- Tyrovolas S, "The role of muscle mass and body fat on disability among older adults: a cross-national analysis", Exp Gerontol, 69, pp.27~35 (2015)
- Studenski SA, "The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates", J Gerontol A Biol Sci Med Sci, 69, pp.547~558 (2014)
- Kim TN, "Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study", Clin Endocrinol, 78, pp.525~532 (2013)
- Srikanthan P, "Relative muscle mass is inversely associated with insulin resistance and prediabetes:findings from the third National Health and Nutrition Examination Survey", J Clin Endocrinol Metab, 96, pp.2898~2903 (2011)
- Meng NH, "Comparison of height- and weight-adjusted sarcopenia in a Taiwanese metropolitan older population", Geriatr Gerontol Int, 15, pp.45~53 (2015)
- Bijlsma AY, "Diagnostic criteria for sarcopenia relate differently to insulin resistance", Age, 35, pp.2367~2375 (2013)
- Scott D, "Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults", Osteoporos Int, 25, pp.187~193 (2014)
- Batsis JA, "Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004", J Am Geriatr Soc, 61, pp.974~980 (2013)